
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
No description available.
This text investigates the clinical efficacy, pharmacological mechanisms, and long-term therapeutic implications of HMG-CoA reductase inhibitors in the management of cardiovascular disease. The authors, Allan Gaw, Christopher J. Packard, and James Shepherd, utilize their extensive backgrounds in clinical biochemistry and lipidology to synthesize decades of research. They present a structured framework that evaluates how these specific inhibitors modulate cholesterol synthesis and influence patient outcomes in diverse clinical populations.
What You Will Find
Medical professionals and researchers frequently cite this work as a foundational reference for understanding the development and application of statin therapy. Experts highlight the text for its clinical rigor and its ability to translate complex biochemical data into practical therapeutic guidance.
Page Count:
0
Publication Date:
2003-01-01
Publisher:
Taylor & Francis Group
ISBN-10:
0203427297
ISBN-13:
9780203427293
No comments yet. Be the first to share your thoughts!